NXSTAGE MEDICAL, INC. NXTM Balance Sheet

Nxstage medical, inc. (NXTM)

Balance Sheet / TTM

Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
ASSETS
Current assets:
Cash and cash equivalents
81,944	76,287	62,619	64,928	62,979	62,839	55,455	59,632	60,817	58,459	57,714	59,065	51,308	48,350	51,012	52,884	62,079	76,829	84,134	83,159	94,297	99,803	106,439	102,679	102,859	102,265	102,909	101,247	100,426	104,339
Accounts receivable, net
66,127	34,506	38,689	31,625	30,245	31,900	39,260	32,286	30,581	30,092	29,083	25,195	30,572	26,401	23,989	24,099	31,086	25,263	20,158	22,523	20,835	22,058	18,990	19,588	17,643	17,626	15,808	17,497	15,889	14,107
Inventory
53,353	50,318	52,118	49,212	50,668	51,230	48,514	46,845	46,877	41,309	39,034	38,391	42,576	43,372	45,277	45,401	43,350	40,804	37,801	37,097	39,349	36,966	33,504	34,879	34,670	34,955	32,775	35,563	39,213	34,950
Prepaid expenses and other current assets
9,819	8,310	9,795	7,609	8,039	9,497	7,999	6,136	5,875	5,921	5,891	6,254	7,054	6,254	6,382	6,767	4,537	4,098	4,027	5,024	4,966	4,825	2,534	1,895	2,084	2,249	2,777	3,104	2,475	2,084
Total current assets
211,243	169,421	163,221	153,374	151,931	155,466	151,228	144,899	144,150	135,781	131,722	128,905	131,510	124,377	126,660	129,151	141,052	146,994	146,120	147,803	159,447	163,652	161,467	159,041	157,256	157,095	154,269	157,411	158,003	155,480
Property and equipment, net
55,106	55,484	59,458	60,262	62,212	62,684	61,323	61,561	65,004	66,374	68,008	66,711	65,203	64,443	64,209	66,574	60,629	56,826	52,478	47,106	42,470	37,317	36,320	33,716	29,049	20,933	17,599	14,276	12,540	8,290
Field equipment, net
22,925	23,848	23,446	24,264	23,793	24,512	24,395	22,309	20,450	20,978	20,385	20,744	19,811	21,104	21,661	21,118	17,808	14,822	13,041	13,670	13,082	10,297	10,101	10,143	9,971	11,562	12,182	12,718	13,036	13,660
Deferred cost of revenues
33,012	32,493	31,568	31,410	31,125	31,610	32,027	33,165	33,972	34,065	33,995	33,068	33,739	33,821	33,798	34,039	33,097	33,815	34,730	33,692	34,305	36,135	38,028	38,391	39,792	39,723	41,132	41,355	40,458	40,081
Intangible assets, net
6,131	6,639	7,154	7,660	8,169	8,675	9,180	9,688	10,202	10,714	11,231	11,744	12,256	12,950	13,629	14,370	15,802	16,491	17,194	17,894	18,587	19,120	19,819	20,518	21,217	21,916	22,615	23,314	24,013	25,412
Goodwill
42,748	42,748	42,748	42,748	42,748	42,648	42,648	42,648	42,710	42,710	42,710	42,710	41,817	41,817	41,817	41,817	41,817	41,817	41,817	42,329	42,313	42,421	42,421	42,698	42,698	42,698	42,698	42,698	42,698	42,698
Other assets
6,284	6,203	6,360	5,911	5,376	2,973	2,975	2,937	2,623	3,074	2,898	2,992	2,525	2,875	2,826	2,657	2,573	1,941	1,582	2,108	2,241	3,261	3,793	3,049	2,066	1,873	1,213	1,497	675	473
Total assets
377,449	336,836	333,955	325,629	325,354	328,568	323,776	317,207	319,111	313,696	310,949	306,874	306,861	301,387	304,600	309,726	312,778	312,706	306,962	304,602	312,445	312,203	311,949	307,556	302,049	295,800	291,708	293,269	291,423	286,094
LIABILITIES AND STOCKHOLDERS EQUITY
Current liabilities:
Accounts payable
19,811	14,958	15,443	14,785	12,871	14,996	18,490	14,177	14,755	13,583	14,104	10,767	12,843	12,790	16,959	13,845	22,525	22,310	14,610	16,798	18,503	20,593	16,645	14,812	14,559	15,717	15,634	19,195	22,620	16,811
Accrued expenses
34,854	31,147	26,193	27,985	28,625	26,933	24,762	30,985	29,335	26,616	24,346	27,266	26,347	22,961	21,139	24,653	21,195	20,538	21,025	18,160	22,015	19,561	20,400	19,337	17,932	16,331	15,165	16,265	14,201	19,537
Current portion of long-term debt
101	99	105	101	99	95	334	328	330	324	322	315	251	249	84	93	103	103	102	-	-	-	-	-	-	-	-	0	16	43
Other current liabilities
3,989	4,185	4,716	4,559	4,602	4,481	4,111	3,770	4,105	4,452	4,530	4,394	4,919	4,858	5,388	6,165	1,870	1,801	1,870	2,516	2,443	2,165	2,187	669	-	-	-	-	-	-
Total current liabilities
58,755	50,389	46,457	47,430	46,197	46,505	47,697	49,260	48,525	44,975	43,302	42,742	44,360	40,858	43,570	44,756	45,693	44,752	37,607	37,474	42,961	42,319	39,232	34,818	32,491	32,048	30,799	35,460	36,837	36,391
Deferred revenues
75,568	47,559	47,205	46,874	47,422	47,658	47,773	49,001	50,969	52,280	52,521	51,362	52,346	51,716	51,697	52,943	51,831	52,242	53,277	52,361	53,401	57,191	59,262	53,565	55,668	55,766	57,014	56,682	55,995	55,366
Long-term debt
444	454	522	520	551	553	1,240	1,305	1,445	1,602	1,617	1,664	1,833	1,841	746	848	1,004	1,030	1,044	-	-	-	-	-	0	43,950	43,235	42,521	41,818	40,454
Other long-term liabilities
17,069	17,164	18,286	17,824	17,994	17,698	16,235	15,568	16,829	16,911	17,616	17,367	18,551	18,522	18,379	19,624	24,030	21,346	20,273	19,676	19,434	15,920	15,864	21,376	18,612	12,126	9,474	6,994	5,639	1,754
Total liabilities
151,836	115,566	112,470	112,648	112,164	112,414	112,945	115,134	117,768	115,768	115,056	113,135	117,090	112,937	114,392	118,171	122,558	119,370	112,201	109,511	115,796	115,430	114,358	109,759	106,771	143,890	140,522	141,657	140,289	133,965
Commitments and contingencies (Note 10)
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Noncontrolling interests subject to put provisions
-291	-197	-171	-165	650	-22	26	50	116	200	200	219	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stockholders equity:
Undesignated preferred stock: par value $0.001 per share, 5,000,000 shares authorized; no shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock: par value $0.001 per share, 100,000,000 shares authorized; 67,756,628 and 67,341,819 shares issued as of September 30, 2018 and December 31, 2017, respectively
68	68	67	67	67	67	66	65	65	65	65	64	64	64	64	63	62	62	61	61	61	60	59	59	59	56	56	55	55	53
Additional paid-in capital
667,620	665,186	660,769	657,640	653,431	647,343	640,907	631,219	626,040	621,395	615,105	612,487	606,780	602,628	598,753	593,073	575,123	571,217	567,468	563,191	560,020	555,850	551,594	549,387	544,997	495,408	489,542	485,191	479,186	465,642
Accumulated deficit
-418,799	-419,680	-416,982	-421,593	-419,324	-410,879	-408,790	-407,601	-406,004	-405,838	-404,106	-402,830	-400,160	-398,473	-393,146	-387,488	-375,930	-368,817	-363,542	-358,366	-353,380	-349,975	-344,981	-342,617	-340,035	-334,972	-329,828	-325,264	-319,986	-308,426
Accumulated other comprehensive loss
-3,527	-4,578	-2,514	-3,673	-1,895	-1,502	-3,196	-6,101	-4,328	-4,250	-2,970	-4,031	-3,951	-3,122	-2,968	-2,192	567	394	212	168	-89	615	470	519	-192	105	-68	146	395	85
Treasury stock, at cost: 1,083,013 and 1,046,870 shares as of September 30, 2018 and December 31, 2017, respectively
20,170	20,170	19,957	19,283	18,955	18,708	18,479	16,184	15,827	15,334	13,906	13,864	13,734	13,734	13,378	12,989	10,010	10,010	9,963	9,963	9,963	9,777	9,551	9,551	9,551	8,687	8,516	8,516	8,516	5,225
Total NxStage Medical, Inc. stockholders' equity
225,192	220,826	221,383	213,158	213,324	216,321	210,508	201,398	199,946	196,038	194,188	191,826	188,999	187,363	189,325	190,467	189,812	192,846	194,236	195,091	196,649	196,773	197,591	197,797	195,278	151,910	151,186	151,612	151,134	152,129
Noncontrolling interests not subject to put provisions
712	641	273	-12	-784	-145	297	625	1,281	1,722	1,500	1,694	772	1,087	883	1,088	408	490	525	-	-	-	-	-	-	-	-	-	-	-
Total stockholders' equity
225,904	221,467	221,656	213,146	212,540	216,176	210,805	202,023	201,227	197,760	195,688	193,520	189,771	188,450	190,208	191,555	190,220	193,336	194,761	-	-	-	197,591	-	-	-	-	-	-	-
Total liabilities and stockholders equity
377,449	336,836	333,955	325,629	325,354	328,568	323,776	317,207	319,111	313,696	310,949	306,874	306,861	301,387	304,600	309,726	312,778	312,706	306,962	304,602	312,445	312,203	311,949	307,556	302,049	295,800	291,708	293,269	291,423	286,094